The Growth in this Embolic Protection Devices Market is mainly attributed to factors such as the rising incidence of cardiovascular and neurovascular diseases, growing funding and investments, the launch of technologically advanced embolic protection devices, and the rising demand for minimally invasive procedures.
The report “Embolic Protection Device Market by Type (Distal Filter, Distal Occlusion, Proximal Occlusion), Material (Nitinol, Polyurethane), Application (Cardiovascular, Neurovascular, Peripheral), Indication (PCI, SVD, TAVR) — Global Forecast to 2023”
The global market is projected to reach $ 604.9 million by 2023, at a CAGR of 8.3% during the forecast period
By indication, the percutaneous coronary intervention segment accounted for the largest market share in 2017
On the basis of indication, the market is categorized into percutaneous coronary intervention, transcatheter aortic valve replacement (TAVR), carotid artery diseases, saphenous vein graft disease, and other indications. In 2017, the percutaneous coronary intervention segment accounted for the largest share of the global embolic protection devices market. The large share of this segment can primarily be attributed to the increasing prevalence of CAD and the rising preference for minimally invasive procedures.
Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158143803
Global Embolic Protection Device Market, By Application
Hospitals are expected to be the largest end users of embolic protection devices during the forecast period
The major end users of embolic protection devices market are hospitals and ambulatory surgical centers. The hospital segment is expected to grow at the highest CAGR during the forecast period. The market for this segment is mainly driven by factors such as the growing number of angioplasty procedures performed in hospitals, rising incidence of chronic vascular diseases, favorable reimbursement scenario in developed countries, growing number of hospitals, and increasing government initiatives to provide quality treatment for cardiovascular diseases.
North America dominated the market. The rising geriatric population and prevalence of cardiovascular and neurovascular diseases, increasing adoption of minimally invasive techniques, increasing availability of funding, and the presence of a large number of medical device product manufacturers are driving the growth of the embolic protection device market in North America.
Request Research Sample Pages:
The prominent players in the embolic protection devices market are Boston Scientific (US), Medtronic (Ireland), Abbott (US), Cordis (A Cardinal Health Company) (US), Allium Medical (Israel), Contego Medical (US), W.L. Gore & Associates (US), Silk Road Medical (US), Claret Medical (US), and AngioSlide (Israel).
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly